These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 16172857)

  • 1. Treatment of severe acute respiratory syndrome.
    Lai ST
    Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):583-91. PubMed ID: 16172857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements in the battle against severe acute respiratory syndrome.
    Hui DS; Wong GW
    Expert Opin Pharmacother; 2004 Aug; 5(8):1687-93. PubMed ID: 15264983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic treatment of SARS: current knowledge and recommendations.
    Tai DY
    Ann Acad Med Singap; 2007 Jun; 36(6):438-43. PubMed ID: 17597972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical issues and research in respiratory failure from severe acute respiratory syndrome.
    Levy MM; Baylor MS; Bernard GR; Fowler R; Franks TJ; Hayden FG; Helfand R; Lapinsky SE; Martin TR; Niederman MS; Rubenfeld GD; Slutsky AS; Stewart TE; Styrt BA; Thompson BT; Harabin AL; ; ;
    Am J Respir Crit Care Med; 2005 Mar; 171(5):518-26. PubMed ID: 15591472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts in SARS treatment.
    Fujii T; Nakamura T; Iwamoto A
    J Infect Chemother; 2004 Feb; 10(1):1-7. PubMed ID: 14991510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical therapy of severe acute respiratory syndrome: 38 cases retrospective analysis].
    Xu YD; Li YM; Liu XQ; Chen SB; He WQ; Xiao ZL; Zhong NS
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Jun; 15(6):343-5. PubMed ID: 12837165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of corticosteroids in SARS.
    Oba Y
    N Engl J Med; 2003 May; 348(20):2034-5; author reply 2034-5. PubMed ID: 12748321
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol.
    Lau AC; So LK; Miu FP; Yung RW; Poon E; Cheung TM; Yam LY
    Respirology; 2004 Jun; 9(2):173-83. PubMed ID: 15182266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS: systematic review of treatment effects.
    Stockman LJ; Bellamy R; Garner P
    PLoS Med; 2006 Sep; 3(9):e343. PubMed ID: 16968120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].
    Rodríguez A; Alvarez-Rocha L; Sirvent JM; Zaragoza R; Nieto M; Arenzana A; Luque P; Socías L; Martín M; Navarro D; Camarena J; Lorente L; Trefler S; Vidaur L; Solé-Violán J; Barcenilla F; Pobo A; Vallés J; Ferri C; Martín-Loeches I; Díaz E; López D; López-Pueyo MJ; Gordo F; del Nogal F; Marqués A; Tormo S; Fuset MP; Pérez F; Bonastre J; Suberviola B; Navas E; León C; ; ;
    Med Intensiva; 2012 Mar; 36(2):103-37. PubMed ID: 22245450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in clinical diagnosis and treatment of severe acute respiratory syndrome.
    Nie QH; Luo XD; Hui WL
    World J Gastroenterol; 2003 Jun; 9(6):1139-43. PubMed ID: 12800213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of ribavirin and corticosteroids for severe acute respiratory syndrome.
    Lau EH; Cowling BJ; Muller MP; Ho LM; Tsang T; Lo SV; Louie M; Leung GM
    Am J Med; 2009 Dec; 122(12):1150.e11-21. PubMed ID: 19958895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS: pharmacotherapy.
    Tsang K; Zhong NS
    Respirology; 2003 Nov; 8 Suppl():S25-30. PubMed ID: 15018130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19.
    Wu L; Zheng Y; Liu J; Luo R; Wu D; Xu P; Wu D; Li X
    Aging (Albany NY); 2021 Apr; 13(8):10833-10852. PubMed ID: 33879634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
    Wang Z; Wang Z
    BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview on severe acute respiratory syndrome (SARS).
    Hui DS
    Monaldi Arch Chest Dis; 2005 Sep; 63(3):149-57. PubMed ID: 16312205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.
    Muller MP; Dresser L; Raboud J; McGeer A; Rea E; Richardson SE; Mazzulli T; Loeb M; Louie M;
    Pharmacotherapy; 2007 Apr; 27(4):494-503. PubMed ID: 17381375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.
    Booth CM; Matukas LM; Tomlinson GA; Rachlis AR; Rose DB; Dwosh HA; Walmsley SL; Mazzulli T; Avendano M; Derkach P; Ephtimios IE; Kitai I; Mederski BD; Shadowitz SB; Gold WL; Hawryluck LA; Rea E; Chenkin JS; Cescon DW; Poutanen SM; Detsky AS
    JAMA; 2003 Jun; 289(21):2801-9. PubMed ID: 12734147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids.
    Jones BM; Ma ES; Peiris JS; Wong PC; Ho JC; Lam B; Lai KN; Tsang KW
    Clin Exp Immunol; 2004 Mar; 135(3):467-73. PubMed ID: 15008980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.